Invention Grant
US08506971B2 Method for adjuvanting lipopolysaccharide (LPS) of gram-negative bacteria
有权
用于佐剂革兰氏阴性菌的脂多糖(LPS)的方法
- Patent Title: Method for adjuvanting lipopolysaccharide (LPS) of gram-negative bacteria
- Patent Title (中): 用于佐剂革兰氏阴性菌的脂多糖(LPS)的方法
-
Application No.: US12780388Application Date: 2010-05-14
-
Publication No.: US08506971B2Publication Date: 2013-08-13
- Inventor: Jean Haensler , Bruno Guy
- Applicant: Jean Haensler , Bruno Guy
- Applicant Address: FR Lyons
- Assignee: Sanofi Pasteur S.A.
- Current Assignee: Sanofi Pasteur S.A.
- Current Assignee Address: FR Lyons
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: FR0902330 20090514
- Main IPC: A61K45/00
- IPC: A61K45/00 ; A61K39/385 ; A61K39/02 ; A61K39/095 ; A01N25/26

Abstract:
The subject of the invention is a method for adjuvanting LPS of a Gram-negative bacterium, according to which LPS or LPS liposomes (LPS formulated in liposomes) is (are) mixed with the lipidated human-transferrin receptor subunit B (TbpB protein) of Neisseria meningitidis or a lipidated fragment thereof; or (ii) LPS and the lipidated TbpB of N. meningitidis or a lipidated fragment thereof are formulated together in liposomes; or (iii) LPS is conjugated with the lipidated TbpB of N. meningitidis or a lipidated fragment thereof; in order to obtain a preparation which does not contain OMVs and which is capable of inducing, after administration to a mammal, an anti-LPS immune response which is improved by comparison with the anti-LPS immune response observed after administration of the corresponding preparation in which the lipidated TbpB of N. meningitidis or a lipidated fragment thereof is omitted; as well as vaccine compositions thereof. The LPS may, for example, be the LOS of a non-enteric Gram-negative bacterium such as N. meningitidis.
Public/Granted literature
- US20110014272A1 Method for adjuvanting lipopolysaccharide (LPS) of Gram-negative bacteria Public/Granted day:2011-01-20
Information query